Intraclot recombinant tissue-type plasminogen activator reduces perihematomal edema and mortality in patients with spontaneous intracerebral hemorrhage

Journal of Huazhong University of Science and Technology - Medical Science

Volumn 34, Issue 2, 2014, Pages 165-171

  Lian, Li Fei ^a   Xu, Feng ^a   Tang, Zhou Ping ^a   Xue, Zheng ^a   Liang, Qi Ming ^a   Hu, Qi ^a   Zhu, Wen Hao ^a   Kang, Hui Cong ^a   Liu, Xiao Yan ^a   Wang, Fu Rong ^a   Zhu, Sui Qiang ^a  

^a HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

Author keywords

clot aspiration; intracerebral hemorrhage; minimally invasive surgery; perihematomal edema; recombinant tissue type plasminogen activator

Indexed keywords

TISSUE PLASMINOGEN ACTIVATOR;

ADULT; AGED; ARTICLE; BRAIN EDEMA; BRAIN HEMORRHAGE; COMPUTER ASSISTED TOMOGRAPHY; FEMALE; HUMAN; MALE; MIDDLE AGED; MINIMALLY INVASIVE SURGERY; MORTALITY; PATHOLOGY; TREATMENT OUTCOME;

ADULT; AGED; BRAIN EDEMA; CEREBRAL HEMORRHAGE; FEMALE; HUMANS; MALE; MIDDLE AGED; SURGICAL PROCEDURES, MINIMALLY INVASIVE; TISSUE PLASMINOGEN ACTIVATOR; TOMOGRAPHY, X-RAY COMPUTED; TREATMENT OUTCOME;

EID: 84898889901     PISSN: 16720733     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11596-014-1252-x     Document Type: Article

References (29)

1. van Asch CJ, Luitse MJ, Rinkel GJ, et al. Incidence, case fatality, and functional outcome of intracerebral haemorrhage over time, according to age, sex, and ethnic origin: a systematic review and meta-analysis. Lancet Neurol, 2010,9(2):167-176
2. Arima H, Wang JG, Huang Y, et al. Significance of perihematomal edema in acute intracerebral hemorrhage: the INTERACT trial. Neurology, 2009,73(23):1963-1968
3. Broderick JP, Brott TG, Duldner JE, et al. Volume of intracerebral hemorrhage. A powerful and easy-to-use predictor of 30-day mortality. Stroke, 1993,24(7):987-993
4. Staykov D, Wagner I, Volbers B, et al. Natural course of perihemorrhagic edema after intracerebral hemorrhage. Stroke, 2011,42(9):2625-2629
5. Zazulia AR, Diringer MN, Derdeyn CP, et al. Progression of mass effect after intracerebral hemorrhage. Stroke, 1999,30(6):1167-1173
6. Carhuapoma JR, Barrett RJ, Keyl PM, et al. Stereotactic aspiration-thrombolysis of intracerebral hemorrhage and its impact on perihematoma brain edema. Neurocrit Care, 2008,8(3):322-329
7. Mould WA, Carhuapoma JR, Muschelli J, et al. Minimally invasive surgery plus recombinant tissue-type plasminogen activator for intracerebral hemorrhage evacuation decreases perihematomal edema. Stroke, 2013,44(3):627-634
8. Wagner KR, Xi G, Hua Y, et al. Ultra-early clot aspiration after lysis with tissue plasminogen activator in a porcine model of intracerebral hemorrhage: edema reduction and blood-brain barrier protection. J Neurosurg, 1999,90(3):491-498
9. Barrett RJ, Hussain R, Coplin WM, et al. Frameless stereotactic aspiration and thrombolysis of spontaneous intracerebral hemorrhage. Neurocrit Care, 2005,3(3):237-245
10. Vespa P, McArthur D, Miller C, et al. Frameless stereotactic aspiration and thrombolysis of deep intracerebral hemorrhage is associated with reduction of hemorrhage volume and neurological improvement. Neurocrit Care, 2005,2(3):274-281
11. Figueroa BE, Keep RF, Betz AL, et al. Plasminogen activators potentiate thrombin-induced brain injury. Stroke, 1998,29(6):1202-1207
12. Rohde V, Rohde I, Thiex R, et al. Fibrinolysis therapy achieved with tissue plasminogen activator and aspiration of the liquefied clot after experimental intracerebral hemorrhage: rapid reduction in hematoma volume but intensification of delayed edema formation. J Neurosurg, 2002,97(4):954-962
13. Rohde V, Uzma N, Thiex R, et al. Management of delayed edema formation after fibrinolytic therapy for intracerebral hematomas: preliminary experimental data. Acta Neurochir Suppl, 2008,105:101-104
14. Thiex R, Kuker W, Muller HD, et al. The long-term effect of recombinant tissue-plasminogen-activator (rt-PA) on edema formation in a large-animal model of intracerebral hemorrhage. Neurol Res, 2003,25(3):254-262
15. Thiex R, Weis J, Krings T, et al. Addition of intravenous N-methyl-D-aspartate receptor antagonists to local fibrinolytic therapy for the optimal treatment of experimental intracerebral hemorrhages. J Neurosurg, 2007,106(2):314-320
16. Ducruet AF, Hickman ZL, Zacharia BE, et al. Exacerbation of perihematomal edema and sterile meningitis with intraventricular administration of tissue plasminogen activator in patients with intracerebral hemorrhage. Neurosurgery, 2010,66(4):648-655
17. Tang ZP, Shi YH, Yin XP, et al. Modifying the details of aspiration operation may contribute to the improvement of prognosis of patients with ICH. Turk Neurosurg, 2012,22(1):13-20
18. Xiao B, Wu FF, Zhang H, et al. A randomized study of urgent computed tomography-based hematoma puncture and aspiration in the emergency department and subsequent evacuation using craniectomy versus craniectomy only. J Neurosurg, 2012,117(3):566-573
19. Xu F, Tang Z, Luo X, et al. No evidence of preoperative hematoma growth representing an increased postoperative rebleeding risk for minimally invasive aspiration and thrombolysis of ICH. Br J Neurosurg, 2010,24(3):268-274
20. Morgenstern LB, Hemphill JC, 3rd, Anderson C, et al. Guidelines for the management of spontaneous intracerebral hemorrhage: a guideline for healthcare professionals from the American Heart Association/American Stroke Association. Stroke, 2010,41(9):2108-2129
21. Hemphill JC 3rd, Bonovich DC, Besmertis L, et al. The ICH score: a simple, reliable grading scale for intracerebral hemorrhage. Stroke, 2001,32(4):891-897
22. Keep RF, Hua Y, Xi G. Intracerebral haemorrhage: mechanisms of injury and therapeutic targets. Lancet Neurol, 2012,11(8):720-731
23. Mayer SA, Sacco RL, Shi T, et al. Neurologic deterioration in noncomatose patients with supratentorial intracerebral hemorrhage. Neurology, 1994,44(8):1379-1384
24. Naff N, Williams MA, Keyl PM, et al. Low-dose recombinant tissue-type plasminogen activator enhances clot resolution in brain hemorrhage: the intraventricular hemorrhage thrombolysis trial. Stroke, 2011,42(11):3009-3016
25. Staykov D, Wagner I, Volbers B, et al. Dose effect of intraventricular fibrinolysis in ventricular hemorrhage. Stroke, 2011,42(7):2061-2064
26. Godoy DA, Pinero G, Di Napoli M. Predicting mortality in spontaneous intracerebral hemorrhage: can modification to original score improve the prediction? Stroke, 2006,37(4):1038-1044
27. Wang W, Lu J, Wang C, et al. Prognostic value of ICH score and ICH-GS score in Chinese intracerebral hemorrhagepatients: analysis from the China National Stroke Registry (CNSR). PLoS One, 2013,8(10):e77421
28. Herrick DB, Ziai WC, Thompson CB, et al. Systemic hematologic status following intraventricular recom-binant tissue-type plasminogen activator for intra-ventricular hemorrhage: the CLEAR IVH Study Group. Stroke, 2011,42(12):3631-3633
29. Zimmerman RD, Maldjian JA, Brun NC, et al. Radiologic estimation of hematoma volume in intracerebral hemorrhage trial by CT scan. AJNR Am J Neuroradiol, 2006,27(3):666-670